DnB Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,853
| Closed | -$282K | – | 743 |
|
|
2024
Q4 | $282K | Sell |
8,853
-75
| -0.8% | -$2.39K | ﹤0.01% | 692 |
|
|
2024
Q3 | $257K | Buy |
8,928
+956
| +12% | +$27.6K | ﹤0.01% | 689 |
|
|
2024
Q2 | $306K | Buy |
7,972
+1,904
| +31% | +$73K | ﹤0.01% | 674 |
|
|
2024
Q1 | $357K | Buy |
+6,068
| New | +$357K | ﹤0.01% | 669 |
|
|
2021
Q1 | – | Sell |
-36,913
| Closed | -$2.11M | – | 635 |
|
|
2020
Q4 | $2.11M | Buy |
+36,913
| New | +$2.11M | 0.02% | 452 |
|